Equity ratings for JAGSONPAL PHARMACE are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of February 2020 and ending today, the 26th of January 2022. Click here to learn more.
JAGSONPAL PHARMACE cannot be verified against its exchange. It appears that JAGSONPAL PHARMACE is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.


Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. JAGSONPAL PHARMACE's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding JAGSONPAL PHARMACE or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
JAGSONPAL PHARMACE is not yet fully synchronised with the market data
JAGSONPAL PHARMACE has some characteristics of a very speculative penny stock
JAGSONPAL PHARMACE is unlikely to experience financial distress in the next 2 years
About 75.0% of the company shares are held by company insiders
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of JAGSONPAL PHARMACE's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
JAGSONPAL PHARMACE (JAGSNPHARM) is traded on National Stock Exchange of India in India . The company currently falls under 'Mid-Cap' category with current market capitalization of 4.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate JAGSONPAL PHARMACE's market, we take the total number of its shares issued and multiply it by JAGSONPAL PHARMACE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. JAGSONPAL PHARMACE operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 26.2 M outstanding shares. JAGSONPAL PHARMACE has accumulated about 602.3 M in cash with 209.56 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 22.95.
Check JAGSONPAL PHARMACE Probability Of Bankruptcy

JAGSONPAL Stock Against Markets

Picking the right benchmark for JAGSONPAL PHARMACE stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in JAGSONPAL PHARMACE stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for JAGSONPAL PHARMACE is critical whether you are bullish or bearish towards JAGSONPAL PHARMACE at a given time.
JAGSONPAL PHARMACE cannot be verified against its exchange. It appears that JAGSONPAL PHARMACE is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with JAGSONPAL PHARMACE stock to make a market-neutral strategy. Peer analysis of JAGSONPAL PHARMACE could also be used in its relative valuation, which is a method of valuing JAGSONPAL PHARMACE by comparing valuation metrics with similar companies.
Check out Risk vs Return Analysis. Note that the JAGSONPAL PHARMACE information on this page should be used as a complementary analysis to other JAGSONPAL PHARMACE's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Other Tools for JAGSONPAL Stock

When running JAGSONPAL PHARMACE price analysis, check to measure JAGSONPAL PHARMACE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JAGSONPAL PHARMACE is operating at the current time. Most of JAGSONPAL PHARMACE's value examination focuses on studying past and present price action to predict the probability of JAGSONPAL PHARMACE's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move JAGSONPAL PHARMACE's price. Additionally, you may evaluate how the addition of JAGSONPAL PHARMACE to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bond Directory
Find actively traded corporate debentures issued by US companies
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk